A Hybrid Effectiveness-Implementation Multisite Trial of a Dialectical Behavior Therapy Skills Group for Veterans at High-Risk for Suicide Attempt
A Hybrid Effectiveness-Implementation Multisite Trial of a Dialectical Behavior Therapy Skills Group for Veterans at High-Risk for Suicide Attempt
批准号:
10541795
负责人:
Suzanne Elizabeth Decker
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-11-01 至 2027-09-30
关键词:
AddressAdministratorAdoptionAffectAftercareCharacteristicsClinicClinicalClinical Practice GuidelineClinical effectivenessComplementCoping SkillsDataDevelopmentDiagnosisDiagnosticDiagnostics ResearchDialectical behavior therapyEffectivenessElementsEmotionsEvaluationFeeling suicidalHealth PersonnelHybridsIndividualInterventionInterviewKnowledgeLeadershipMachine LearningMeasuresMedical centerMental HealthMental Health ServicesMental disordersMethodologyMethodsOutcomeOutpatientsParticipantPhasePreventionProcessPromoting Action on Research Implementation in Health Services frameworkPsychotherapyPublished CommentRandomizedRandomized, Controlled TrialsResearchResourcesRisk FactorsSafetySamplingSiteStructureSuicideSuicide attemptSuicide preventionSystemTestingTimeVeteransclinical research siteeffectiveness evaluationeffectiveness testingeffectiveness trialeffectiveness/implementation hybridemotion dysregulationemotion regulationevidence basefollow-upformative assessmenthigh riskhybrid type 1 trialimplementation barriersimplementation facilitatorsimplementation strategyimprovedinnovationmilitary veteranmulti-site trialoperationpreventprimary outcomeprocess improvementprogramspsychologicrandomized trialreducing suicidescreeningskillssuicidal morbiditysuicidal risktreatment as usualtreatment groupuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract.
Background: Suicide prevention is VHA’s highest priority. While VHA has responded by implementing new
screening requirements, the REACH VET machine-learning program to identify those at high risk, and new
clinical practice guidelines, these approaches do not provide Veterans at highest suicide risk with “indicated”
strategies, such as psychotherapy that specifically targets suicide attempts. Reducing Veteran suicide attempts
requires addressing underlying transdiagnostic psychological processes. Emotion dysregulation, or difficulty
managing emotions, occurs across mental health diagnoses and is associated with higher suicide risk.
Developing emotion regulation skills is a key element of effective suicide prevention. Dialectical behavior
therapy (DBT) is a well-established, multi-component, evidence-based suicide prevention psychotherapy
targeting emotion dysregulation that is not widely available at VHA given the complexities of implementing it. A
resource-efficient, group-delivered suicide prevention psychotherapy, DBT Skills Group (DBT-SG), has been
associated with reduced suicidal ideation and emotion dysregulation in VHA and non-VHA samples and was
as effective as full-scale DBT in reducing suicide attempt and ideation in a non-VHA study of individuals with
high suicide risk. We propose a hybrid type 1 trial to 1) evaluate the effectiveness of DBT-SG in a
transdiagnostic sample of Veterans at high risk for suicide, and 2) identify individual and organizational barriers
and facilitators for DBT-SG adoption in VHA facilities. Significance/ Impact: Studying DBT-SG’s clinical
effectiveness and factors affecting its implementation align with the OMHSP’s National Strategy for Preventing
Veteran Suicide, HSR&D, and legislative priorities to evaluate innovative interventions in high risk Veteran
populations, and new VHA Clinical Practice Guidelines that encourage transdiagnostic research on DBT
approaches for high-risk Veterans. Innovation: This study fills VHA and national research gaps: it is the first
multisite trial to test the effectiveness of DBT-SG at VHA while simultaneously gathering generalizable
knowledge about implementation barriers and facilitators. Outcomes on clinical effectiveness and barriers and
facilitators will be used by OMHSP Psychotherapy and Suicide Prevention offices to inform ongoing suicide
prevention initiatives. Specific Aims: (1) Test the effectiveness of DBT-SG compared to treatment-as-usual
(TAU) to reduce suicide attempt and ideation in a multisite randomized trial at 4 VAMC’s; (2) Conduct a 3-part,
mixed-methods formative evaluation to identify potential facilitators and barriers to DBT-SG’s successful
adoption in VHA facilities. Methodology: We will randomize N=254 Veterans across 4 VAMC’s with recent
suicide attempt and emotion dysregulation to DBT-SG + TAU or TAU alone to evaluate DBT-SG effectiveness.
We hypothesize that DBT-SG, relative to TAU, will be associated with (H1a, primary outcome) reduced suicide
attempt during 18-month follow-up, (H2b) increased survival time for suicide attempt, and (H2c) reduced
suicidal ideation. Exploratory analyses will assess change in emotion dysregulation and coping skills. In
addition, before, during and after the trial, we will conduct a mixed-method formative evaluation, guided by the
Integrated Promoting Action on Research Implementation in Health Services (i-PARIHS) framework, to identify
DBT-SG implementation barriers and facilitators. At each juncture, we will seek input from 60 key clinical and
administrative stakeholders drawn from VHA national and local leadership, VHA clinicians, and Veterans at
high risk for suicide. Implementation/Next Steps: Effectiveness trial data about the prevention or delay of
suicide attempts will determine the appropriateness of DBT-SG for more widespread VHA implementation. If
DBT-SG is effective, the 3-part formative evaluation data will be used to develop a national VA DBT-SG
implementation strategy with OMHSP’s Psychotherapy Office as the operations partner. In each project year,
we will disseminate study findings to Veterans, VHA clinicians, and VHA local and national leadership.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金